Kyosuke Matsuzaki

Years Active: 2018-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Taigo Kato, Satoru Yumiba, Wataru Nakata, Kosuke Nakano, Akira Nagahara, Kyosuke Matsuzaki, Yujiro Hayashi, Koji Hatano, Atsunari Kawashima, Tetsuya Takao, Kensaku Nishimura, Yasutomo Nakai, Masashi Nakayama, Kazuo Nishimura, Shingo Takada, Masao Tsujihata, Motohide Uemura, Norio Nonomura, Ryoichi Imamura
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan. International journal of urology : official journal of the Japanese Urological Association (2022)
Eisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, Takashi Shiromizu, Ryohei Narumi, Kentaro Jingushi, Yoko Koh, Makoto Matsushita, Kosuke Nakano, Yujiro Hayashi, Cong Wang, Yu Ishizuya, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Motohide Uemura, Tetsuya Takao, Jun Adachi, Takeshi Tomonaga, Norio Nonomura
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers. Cancer science 112 (5) (2021)
Kyosuke Matsuzaki, Kazutoshi Fujita, Yujiro Hayashi, Makoto Matsushita, Satoshi Nojima, Kentaro Jingushi, Taigo Kato, Atsunari Kawashima, Takeshi Ujike, Akira Nagahara, Motohide Uemura, Ryoichi Imamura, Seiji Yamaguchi, Hiroaki Fushimi, Hiroshi Miyamoto, Eiichi Morii, Norio Nonomura
STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma. PloS one 13 (8) (2018)

Kyosuke Matsuzaki.css-eqlu8i{font-size:small;padding-left:4px;}